New Site Acquisition at Huntingwood NSW

Due to an increase in demands of our products, production capabilities and business growth, GMP Pharmaceuticals took an opportunity to expand with the acquisition of a new site location. GMP acquired the former Sony DADL Australia site in 2018. Once fully operational, it will create more than 400 new jobs at the state-of-the-art facility and will feature new product lines as well as expanding on existing lines. The modern facility reflects GMP’s professionalism and projects a confident image for customers and business partners.